Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Juan Carlos Borrego-Moreno has a total of 85 co-authors. Here are the top co-authors by number of shared publications:

  • Yamilé López-Hernández

    CONACYT, Laboratorio de Metabolómica y Proteomica, Unidad Académica de Ciencias Biológicas, Universidad Autónoma de Zacatecas, Av. Preparatoria No. 301, Zacatecas 98068, Mexico

    6 shared publications
  • Jesús Adrián López

    MicroRNAs and Cancer Laboratory, Academic Unit of Biological Sciences, Autonomous University of Zacatecas, Zacatecas, Mexico

    5 shared publications
  • Jiamin Zheng

    The Metabolomics Innovation Centre, University of Alberta, Edmonton, Canada

    3 shared publications
  • Joel Monárrez-Espino

    Department of Health Research, Christus Muguerza del Parque Hospital – University of Monterrey, Chihuahua, Mexico

    3 shared publications
  • Juan José Oropeza-Valdez

    Centro de Ciencias de la Complejidad, Universidad Nacional Autónoma de México (UNAM), Mexico City 04510, Mexico

    3 shared publications
  • Rupasri Mandal

    The Metabolomics Innovation Centre, University of Alberta, Edmonton, Canada

    3 shared publications

Latest Publications

  • Open Access

    Reacción de hipersensibilidad inmediata aguda durante la terapia con antiveneno F(ab’)2 por envenenamiento grado II por serpiente de cascabel: reporte de caso en México

    by Georgina Flores Martini, Juan Carlos Borrego Moreno, Ana Elizabeth de la Cruz Reyes, Blanca Idalia Cardiel Méndez, Ernesto Deloya Tómas, Elizabeth Guadalupe Haro Cruz, Maria Julieta Cárdenas de Luna

    Rattlesnake envenomation remains a relevant cause of morbidity in Mexico, and antivenom is still the specific treatment of choice. We report the case of a 35-year-old man with grade II rattlesnake envenomation affecting the left hand, initially managed with six vials of equine polyvalent F(ab’)2 antivenom, analgesia, local supportive care, and serial clinical and laboratory monitoring. Approximately 30 minutes after antivenom administration, he developed fever, generalized pruritus, urticaria, and mild dyspnea, without hypotension, active bleeding, neurologic deterioration, or objective evidence of systemic venom progression. The event was interpreted as an acute immediate hypersensitivity reaction related to antivenom therapy. Symptom-directed treatment with antihistamines and corticosteroids was given, and antivenom was temporarily withheld for 24 hours. Because local edema persisted, antivenom was reintroduced under close monitoring and was well tolerated. The patient was readmitted one week later because of persistent edema, received additional antivenom according to clinical judgment, and showed favorable progression. This case highlights the importance of distinguishing venom progression from treatment-related hypersensitivity to support safe continuation of specific therapy when still clinically indicated.

  • Open Access

    [From ICU to recovery: recurrent pneumonia due to Lophomonas blattarum].

    by María Julieta Cárdenas-De Luna, Evelin Bugarin-Cortes, Carlos Fernando Gómez-Rodríguez, Luis Adrián De Jesus-González, Juan Carlos Borrego-Moreno

    Lophomonas blattarum is a multiflagellate protozoan considered an endocommensal parasite of the cockroach gut. Its identification is clinically relevant in cases of recurrent or refractory pneumonia. The infection manifests with cough, dyspnea, expectoration, bronchiectasis, and pleural effusion; its diagnosis is based on the morphological recognition of the protozoan in respiratory samples, and treatment with metronidazole or tinidazole is usually effective. To describe the manifestations, diagnostic findings, and evolution of a patient with recurrent pneumonia caused by Lophomonas blattarum, the following case is presented. A 73-year-old female patient with type 2 diabetes mellitus, hypertension, hypothyroidism, and depressive disorder, with a history of hospitalization for pneumonia, was admitted with chest pain, progressive dyspnea, hyporexia, edema, and perioral cyanosis. Laboratory studies revealed a ground-glass opacity pattern and bilateral alveolar infiltrates. Given the poor response to treatment, bronchoalveolar lavage was performed, and Lophomonas blattarum was identified by direct microscopy. Treatment with metronidazole was initiated, resulting in clinical improvement and resolution. This case highlights the importance of considering parasitic etiologies in patients with recurrent pneumonia and chronic comorbidities. The timely identification of Lophomonas blattarum by bronchoalveolar lavage allowed for targeted treatment and a favorable clinical outcome.

  • Open Access

    Risks, complications, and protective factors for health in pregnant adolescent workers in agricultural fields

    by Karla M. Morales-González, Claudia N. Orozco-Gonzalez, Luis Adrián De Jesús-González, Adrian Canizalez-Roman, Nidia Leon-Sicairos, Maria Julieta Cardenas de Luna, Juan Carlos Borrego-Moreno

    Pregnant adolescents working in agricultural settings face several obstacles due to their age, educational limitations, and harsh working conditions, which may increase pregnancy-related risks. This situation highlights the urgent need for comprehensive support strategies that target these risk factors, ultimately leading to a more favorable outlook for young mothers and their children. Objective: To analyze the factors mainly associated with complications in pregnant working adolescents from 2018 to 2021. Material and Methods: A qualitative experimental study was conducted on 250 working and non-working pregnant adolescents living in the agricultural fields of Vizcaino, Baja California Sur. Data were collected through personal interviews, group discussions, and documentary reviews. Results: The general sociodemographic data revealed a mean age of 17 years, with an age range of 14 to 19 years. Sixty-four percent of the patients reported being in a couple, and 23% were single. The mean body mass index (BMI) was 22.8 ± 5.5. Regarding education, 40% of the participants reported primary education as their highest level, followed by 29% who had completed secondary education. Elementary education was identified as a risk factor related to pregnancy complications (RR 37.931, CI 8.379-171.709). A significant 65.2% of the respondents working as agricultural laborers reported working between 6 and 8 hours daily, including 1 hour for meals. This work pattern was also linked to an increased risk of pregnancy complications (RR 7.357, CI 2.715-19.938). Conclusions: There is a significant public health problem among pregnant adolescent women of farm communities, with complications observed in more than a third of the patients.

  • Open Access

    Lesión renal aguda por mordedura de Latrodectus geometricus (araña viuda marrón). Primer reporte en México

    by Georgina Flores-Martini, Anuar Cisneros-Pérez, Diego A. González-García, Fátima P. Ávila-Hernández, Juan C. Borrego-Moreno

    Se han documentado pocos casos de envenenamiento por Latrodectus geometricus (viuda marrón) en Latinoamérica y ninguno en México. Este c...

  • Open Access

    Perspective Chapter: Diabetes as a Post-COVID Syndrome – Possible Mechanisms Involved

    by Adrian Canizalez-Roman, Uriel A. Angulo-Zamudio, Roberto A. Ayala-Manjarez, Juan C. Borrego-Moreno, Francisco A. Martínez-Villa, Héctor M. Flores-Villaseñor, Nidia León-Sicairos

    There is a well-established association between hyperglycemia and severe coronavirus 2019 (COVID-19) infection. During the SARS-CoV-2 pandemic, mortality was higher in patients with type II diabetes mellitus (DM) than in those without DM. In addition, readmission and COVID-19 reinfection rates were similar in both groups. Evidence shows that individuals who have had COVID-19 are at a significantly increased risk of developing new-onset diabetes mellitus in the post-infection phase. The current literature suggests that direct cytotoxic effects of the virus and inflammation are possible pathophysiological mechanisms. In this chapter, we review the association between COVID-19 infection and new-onset diabetes mellitus after acute infection and discuss the available evidence on the mechanisms of action involved. These findings may have significant implications for understanding and managing COVID-19 and diabetes.

  • Quiste dermoide de ovario con presentación atípica juvenil: reporte de caso clínico

    by Marcy Ethel Espínola Latournerie Cerino, Jesús Kumul Canché Binui, Jorge Carballo Araujo, Juan Carlos Borrego-Moreno

    Introducción: Los tumores de células germinales son un grupo diverso de neoplasias que representan alrededor del 20% al 25% de todos los tumores de ovario. Estos tumores afectan principalmente a personas jóvenes y constituyen la mayoría de los tumores que se encuentran en los niños. La aparición de teratomas quísticos maduros es baja, oscilando entre 1,2 y 14,2 casos por 100.000 personas por año, y normalmente se descubren de forma incidental. Caso clínico: Se presenta caso de un paciente femenino 17 años, nuligesta sin inicio de vida sexual, ni comorbilidades, presenta cirugía conservadora tumor anexial en 2017 por teratoma ovárico derecho sin complicaciones. Se identifica nueva masa aproximadamente 21x15x10cm anexo izquierdo con alta sospecha de benignidad según criterios de IOTA por ultrasonido y marcadores tumorales negativos. Se realiza cirugía extractora de tumoración, histológicamente con resultado de teratoma quístico maduro, tumoración de 19 cm de diámetro mayor con cápsula íntegra, salpinge edematosa y congestiva. Esta paciente contaba con el antecedente de un teratoma previo contralateral de menor tamaño con histología benigna y presenta de novo una masa en el anexo contralateral de proporciones exageradas que saca de contexto las características clásicas del quiste dermoide ovárico.

  • Open Access

    Acute Kidney Injury in the Context of COVID-19: An Analysis in Hospitalized Mexican Patients

    by Juan Carlos Borrego-Moreno, María Julieta Cárdenas-De Luna, José Carlos Márquez-Castillo, José Manuel Reyes-Ruiz, Juan Fidel Osuna-Ramos, Moisés León-Juárez, Rosa María del Ángel, Adrián Rodríguez-Carlos, Bruno Rivas-Santiago, Carlos Noe Farfan-Morales, et al.

    During the COVID-19 pandemic, a considerable proportion of patients developed a severe condition that included respiratory failure, shock, or multiple organ dysfunction. Acute Kidney Injury (AKI) has been recognized as a possible cause of severe COVID-19 development. Given this, this study investigates the occurrence and consequences of AKI in Mexican patients to contribute to better knowledge and management of this problem. Methods: Using a retrospective observational cohort methodology, we investigated 313 cases from a cohort of 1019 patients diagnosed with COVID-19 at the IMSS Zacatecas General Hospital of Zone No. 1 in 2020. The prevalence of AKI was determined using the AKIN criteria based on serum creatinine levels and a detailed review of demographic characteristics, medical history, comorbidities, and clinical development. Results: The data showed a 25.30% prevalence of AKI among patients infected with severe COVID-19. Remarkably, these patients with AKI exhibited an advanced age (>65 years), arterial hypertension, a higher number of white blood cells during admission and the hospital stay, and elevated levels of C-reactive protein, serum creatinine, and blood urea nitrogen (BUN). Clinically, patients with AKI had signs of prostration, pneumonia, and the requirement for ventilatory assistance when compared to those without AKI. Finally, those diagnosed with AKI and COVID-19 had a 74% death rate. Relative risk analyses indicated that age (>65 years), arterial hypertension, high creatinine levels, endotracheal intubation, and pneumonia are associated with the development of AKI. On the other hand, among the protective factors against AKI, high hemoglobin levels and the consumption of statins during COVID-19 were found. Conclusions: The findings of this study underscore the significance of promptly identifying and effectively managing AKI to potentially alleviate the negative consequences of this complication within the Mexican population during COVID-19.


  • Top Cited Papers
    Open Access

    The plasma metabolome of long COVID patients two years after infection

    by Yamilé López-Hernández, Joel Monárrez-Espino, David Alejandro García López, Jiamin Zheng, Juan Carlos Borrego, Claudia Torres-Calzada, José Pedro Elizalde-Díaz, Rupasri Mandal, Mark Berjanskii, Eduardo Martínez-Martínez, et al.

    One of the major challenges currently faced by global health systems is the prolonged COVID-19 syndrome (also known as “long COVID”) which has emerged as a consequence of the SARS-CoV-2 epidemic. It is estimated that at least 30% of patients who have had COVID-19 will develop long COVID. In this study, our goal was to assess the plasma metabolome in a total of 100 samples collected from healthy controls, COVID-19 patients, and long COVID patients recruited in Mexico between 2020 and 2022. A targeted metabolomics approach using a combination of LC–MS/MS and FIA MS/MS was performed to quantify 108 metabolites. IL-17 and leptin were measured in long COVID patients by immunoenzymatic assay. The comparison of paired COVID-19/long COVID-19 samples revealed 53 metabolites that were statistically different. Compared to controls, 27 metabolites remained dysregulated even after two years. Post-COVID-19 patients displayed a heterogeneous metabolic profile. Lactic acid, lactate/pyruvate ratio, ornithine/citrulline ratio, and arginine were identified as the most relevant metabolites for distinguishing patients with more complicated long COVID evolution. Additionally, IL-17 levels were significantly increased in these patients. Mitochondrial dysfunction, redox state imbalance, impaired energy metabolism, and chronic immune dysregulation are likely to be the main hallmarks of long COVID even two years after acute COVID-19 infection.


  • Open Access

    Untargeted analysis in post-COVID-19 patients reveals dysregulated lipid pathways two years after recovery

    by Yamilé López-Hernández, Juan José Oropeza-Valdez, David Alejandro García Lopez, Juan Carlos Borrego, Michel Murgu, Jorge Valdez, Jesús Adrián López, Joel Monárrez-Espino

    Introduction: Similar to what it has been reported with preceding viral epidemics (such as MERS, SARS, or influenza), SARS-CoV-2 infection is also affecting the human immunometabolism with long-term consequences. Even with underreporting, an accumulated of almost 650 million people have been infected and 620 million recovered since the start of the pandemic; therefore, the impact of these long-term consequences in the world population could be significant. Recently, the World Health Organization recognized the post-COVID syndrome as a new entity, and guidelines are being established to manage and treat this new condition. However, there is still uncertainty about the molecular mechanisms behind the large number of symptoms reported worldwide.Aims and Methods: In this study we aimed to evaluate the clinical and lipidomic profiles (using non-targeted lipidomics) of recovered patients who had a mild and severe COVID-19 infection (acute phase, first epidemic wave); the assessment was made two years after the initial infection.Results: Fatigue (59%) and musculoskeletal (50%) symptoms as the most relevant and persistent. Functional analyses revealed that sterols, bile acids, isoprenoids, and fatty esters were the predicted metabolic pathways affected in both COVID-19 and post-COVID-19 patients. Principal Component Analysis showed differences between study groups. Several species of phosphatidylcholines and sphingomyelins were identified and expressed in higher levels in post-COVID-19 patients compared to controls. The paired analysis (comparing patients with an active infection and 2 years after recovery) show 170 dysregulated features. The relationship of such metabolic dysregulations with the clinical symptoms, point to the importance of developing diagnostic and therapeuthic markers based on cell signaling pathways.


  • Open Access

    COVID-19 Outcome Prediction by Integrating Clinical and Metabolic Data using Machine Learning Algorithms

    by Karen E. Villagrana-Bañuelos, Valeria Maeda-Gutiérrez, Vanessa Alcalá-Rmz, Juan J. Oropeza-Valdez, Ana S. Herrera-Van Oostdam, Julio E. Castañeda-Delgado, Jesús Adrián López, Juan C. Borrego Moreno, Carlos E. Galván-Tejada, Jorge I. Galván-Tejeda, et al.

    The coronavirus disease (COVID-19) is an infectious disease caused by the SARS-CoV-2 virus and is responsible for nearly 6 million deaths worldwide in the past 2 years. Machine learning (ML) models could help physicians in identifying high-risk individuals. To study the use of ML models for COVID-19 prediction outcomes using clinical data and a combination of clinical and metabolic data, measured in a metabolomics facility from a public university. A total of 154 patients were included in the study. "Basic profile" was considered with clinical and demographic variables (33 variables), whereas in the "extended profile," metabolomic and immunological variables were also considered (156 characteristics). A selection of features was carried out for each of the profiles with a genetic algorithm (GA) and random forest models were trained and tested to predict each of the stages of COVID-19. The model based on extended profile was more useful in early stages of the disease. Models based on clinical data were preferred for predicting severe and critical illness and death. ML detected trimethylamine N-oxide, lipid mediators, and neutrophil/lymphocyte ratio as important variables. ML and GAs provided adequate models to predict COVID-19 outcomes in patients with different severity grades.